País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
Bismuth subnitrate
Cross Vetpharm Group Limited
QJ51X
Bismuth subnitrate
2.6 g/syringe
Intramammary Infusion
LM: Licensed Merchant as defined in relevant national legislation
Cattle
OTHER ANTIBACTERIALS FOR INTRAMAMMARY USE
Miscellaneous
Authorised
2003-06-30
Health Products Regulatory Authority 08 January 2018 CRN000WLS Page 1 of 5 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Boviseal Dry Cow Intramammary Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Bismuth subnitrate 2.6g per 4g syringe For a full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Intramammary infusion, dry cow.Grey to white coloured cream. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dairy cows at the end of lactation. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Boviseal is indicated for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of subclinical mastitis in cows at calving, and of clinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving). It is recommended that Boviseal be used as part of a herd approach to dry cow management and mastitis control. Cows considered likely to be free of subclinical mastitis should be given Boviseal at drying off according to the criteria below. Other animals should be managed in accordance with an approved mastitis control plan or specific veterinary advice. For practical purposes, selection criteria may be based on the mastitis and cell count history of individual cows, or recognised tests for the detection of subclinical mastitis or bacteriological sampling. It is particularly important that, prior to treatment, an individual cell count be obtained from any cow with a history of clinical mastitis during the previous lactation. As a guide, cows with an average cell count less than 200,000 cells/ml before drying off may be given Boviseal. A minor increase (cell count up to 250,000 cells/ml) during the last 4 weeks before drying off is normal and may be ignored. In case of doubt, veterinary advice should be sought. Health Products Regulatory Authority 08 January 2018 CRN000WLS Page 2 of 5 4.3 CONTRAINDICATIONS Do not use in the lactating cow. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Details provided above apply. Leer el documento completo